Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Grosspotzl, M; Seidel, G; Rabensteiner, D; Haas, A.
Frequency of submacular hemorrhage in age-related macular degeneration in time periods of different therapeutic modalities
SPEKTRUM AUGENHEILKD. 2015; 29(4): 149-152.
Doi: 10.1007/s00717-014-0244-3
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Großpötzl Manuel
- Co-Autor*innen der Med Uni Graz
- Haas Anton
- Rabensteiner Dieter Franz
- Seidel Gerald
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- One of the most vision threatening complications of exsudative age-related macular degneration (AMD) are submacular hemorrhages. The aim of this study was to investigate the difference in the incidence of submacular hemorrhages between laser photocoagulation, photodynamic therapy with verteporfin (PDT) and Anti-VEGF-therapy of treated and untreated cases. We reviewed 4367 patients diagnosed with exsudative AMD regarding the appearance of submacular hemorrhages (99 patients) during the years 1997-2012. There was a significantly higher occurrence of submacular hemorrhage (OR 1959) in patients without therapy than in treated patients. There was, however, no significant difference between the three therapeutic options in regard to the incidence of submacular hemorrhages. The risk of submacular hemorrhage after therapeutic intervention is significantly lower than in patients with AMD without treatment. However, an Anti-VEGF therapy cannot prevent submacular hemorrhage.
- Find related publications in this database (Keywords)
- Submacular hemorrhage
- Age-related macular degeneration
- Laser photocoagulation
- Photodynamic therapy
- Anti-VEGF